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WS2.1 “Feeling my way”: Information needs for parents whose child
has been diagnosed with CF following newborn screening
M. Jessup1, L. Shields2, S. Grogan3, C.A. Branch-Smith3, T.A. Douglas, on behalf
of AREST CF4. 1Australian Catholic University/The Prince Charles Hospital,
Research Centre, Brisbane, Australia; 2James Cook University/Townsville Hospital
and Health District, Tropical Health Research Unit, Townsville, Australia;
3Telethon Institute for Child Health Research, Perth, Australia; 4Curtin University/
Princess Margaret Hospital for Children, Perth, Australia
Objectives: To investigate education needs and information seeking behaviours
of parents whose infant is diagnosed with CF. Initial diagnosis and education
are landmark events for parents whose child has CF. Education delivery and
content exert powerful inﬂuences on parental adjustment to diagnosis and ongoing
engagement with the CF team. Despite the introduction of NBS over 20 years ago
in Australia, there is a dearth of studies investigating education needs of parents
during this pivotal period. Even with good intentions, current practices may fail to
meet parents’ information and care needs.
Method: In depth interviews were conducted with parents (N = 10) of an infant aged
from 1 to 3 years diagnosed with CF following NBS. Thematic analysis revealed a
sense of parents being overwhelmed with too much startling information too soon
for some; and a desire for education delivery at intervals over the ﬁrst year. Most
wanted more pragmatic information about aspects of treatment and disease they
could modify/inﬂuence, and the impact of infection control measures on lifestyle.
Many perceived their independent search for information a negative experience.
Participants offered constructive insight into factors affecting their engagement with
the process, and recommendations for more appropriate context, content, format and
timing of delivery.
Conclusion: Insight into education content and delivery, optimal timing and
environment for this initial period of diagnosis and education from a parental
perspective is requisite so that relevant, accurate education can be developed and
provided in a format (such as web-based materials) that is readily accessed by
parents.
WS2.2 What do parents experience and how do they cope with the
AREST CF early surveillance program for infants and children
with cystic ﬁbrosis?
C.A. Branch-Smith1,2, J. Pooley2, L. Shields3, S.M. Stick1,4, T.A. Douglas4,5,
on behalf of AREST CF. 1Telethon Institute for Child Health Research, Centre
for Child Health Research, The University of Western Australia, Perth, Australia;
2Edith Cowan University, School of Psychology and Social Science, Perth,
Australia; 3James Cook University, School of Nursing, Midwifery and Nutrition,
Townsville, Australia; 4University of Western Australia, School of Paediatric and
Child Health, Perth, Australia; 5Curtin University, School of Psychology, Perth,
Australia
Background: The Australian Early Surveillance Team for Cystic Fibrosis
(AREST CF) runs a unique clinical early pulmonary surveillance program (EPSP)
for preschool children and infants with CF from diagnosis following NBS. Children
undergo annual bronchoscopy and CT scan thorax under general anaesthetic to
detect signs of early lung disease. Parental experiences of their child’s engagement
in this program remain largely unknown and warrant exploration.
Aim: To explore and report the range of psychosocial experiences of parents whose
children are enrolled in the EPSP and to characterise coping styles and strategies.
Methods: A qualitative research design of semi-structured interviews for parents
of children with CF. Parents were randomly selected from the purposive sample of
patients attending Perth CF Clinic. 16 parents (5 fathers, 11 mothers) of children
aged 1−6 years (M= 3 years) participated. Items explored emotional, social and
family experiences related to the annual surveillance program. Thematic analysis
identiﬁed common experiences and emergent themes.
Results: Dominant themes included anxiety and fearfulness regarding the surveil-
lance procedures, the perceived risks associated with these and anticipated distress
of their child. Coping strategies included distraction, denial and cognitive re-
framing. Most perceived the EPSP as beneﬁcial for their child’s future. Under-
standing and prior experience of procedures and the reasons for them aided parental
coping.
Conclusions: This is the ﬁrst study of how parents experience and cope with the
EPSP and data will inform design and implementation of psychosocial supports for
families within the EPSP.
WS2.3 Parents’ roles and involvement in young adults’ clinic
appointments
B. Beresford1, L. Stuttard1. 1University of York, SPRU, York, United Kingdom
Objectives: To describe young adults’ views and preferences regarding their
parents’ roles and involvement in clinic appointments in adult health settings, and
parents’ explanations of their level of involvement.
Methods: Qualitative, semi-structured interviews with 34 young adults (aged
17−25 yrs) with childhood diagnosed chronic conditions including cystic ﬁbrosis
(n = 12), muscular dystrophies and renal disease, and 19 parents (recruited via young
adult participants).
Conclusion: Independence in other areas of the young adults’ lives did not predict a
lack of parental involvement in appointments. Parents assumed similar roles to other
‘companions’ accompanying patients to clinic, namely: communicator, information
receiver and emotional support. Young adults wanted parents to attend appointments
with them, either routinely, or when difﬁcult information/signiﬁcant decisions were
expected, or the young adult was struggling to communicate with the team. They
valued being able to ‘recall’ their parents to being involved in consultations. Parents
not attending were often involved in priming, de-brieﬁng and/or providing emotional
support. Parents who remained highly involved in appointments explained this in
terms of the young adult’s lack of maturity and/or understanding of their condition
and its treatment regime. The life-threatening nature of the condition meant some
believed not attending appointments was too risky. Companions are typically viewed
positively by health professionals yet a parent’s presence in adult clinics can be
problematised. The ﬁndings reported suggest the rationale for taking this different
view may be simplistic and requires further scrutiny.
WS2.4 Use of non-prescribed medicines, supplements and therapies
by children with cystic ﬁbrosis, other chronic illnesses and
children with an acute injury − A comparative mixed-methods
study
M. Hurley1, J. Ho2, J. Gates2, A. Gaunt3, A.R. Smyth1. 1University of Nottingham,
Academic Department of Child Health, Nottingham, United Kingdom; 2University
of Nottingham, Medical School, Nottingham, United Kingdom; 3University of
Warwick, Warwick, United Kingdom
Aims:
– To quantify, describe and compare non-prescribed agent (NPA) use by children
with cystic ﬁbrosis (CF), other chronic illness and no chronic illness
– To explore families’ motivations for giving (or not giving) NPAs.
Methods: A questionnaire and semi-structured interview study using an explanatory
sequential approach recruiting parents of children attending CF, haemato-oncology,
neurology, development and fracture clinics, Oct-Dec 2011. Quantitative data
were analysed using descriptive statistics, chi-squared and multivariate analysis.
Qualitative data, collected from interviews until data saturation, were coded and
thematically analysed by three independent researchers.
Results: 295 questionnaires were completed, 44 children had CF (14.9%). Response
rate-44.4%, 60.3% male, mean age 9.2 years. Prevalence of NPA use was 37.3%
overall (CF = 34.1%). Speciﬁc prevalences − 10% ﬁsh oils, 16% vitamins, 15%
probiotics, less commonly noted included homeopathy and hyperbaric oxygen.
Differences in NPA use between clinics were not signiﬁcant (p= 0.21). NPA use
was not associated with age, gender or socioeconomic status. Sixteen parents
completed interviews (3 CF). Ten themes were identiﬁed. Those describing why
parents provided NPAs included a wish to take an active role, trust (in health
professionals, or remedy of choice) and accessibility of doctors/NPAs.
Conclusions: This is the ﬁrst UK-based study to compare NPA use between children
with CF, other chronic illness and no chronic illness. Children with CF were no
more likely to take NPA’s than other children. Parental motivators are complex,
relate to intent, trust, and a wish to take an active role in their child’s healthcare.
